학술논문
Canakinumab Lacks Efficacy in Treating Adult Patients with Moderate to Severe Chronic Spontaneous Urticaria in a Phase II Randomized Double-Blind Placebo-Controlled Single-Center Study
Document Type
Article
Author
Source
In The Journal of Allergy and Clinical Immunology: In Practice January 2021 9(1):463-468
Subject
Language
ISSN
2213-2198